Ken Greenberg: Can Ultrasound Shatter the Gene Therapy Delivery Bottleneck?
Aug 26, 2026
If its promising animal results translate to humans, SonoThera’s ultrasound and microbubbles could enable larger payloads, repeat dosing, and precise tissue targeting for gene therapy.…
Read More –Measuring ER Positivity as a Spectrum Could Improve Breast Cancer Care
Aug 26, 2026Can BriaCell Beat Merck and Moderna’s Breakthrough Personalized Melanoma Vaccine?
Aug 26, 2026‘TumorDressed’ Allogeneic Dendritic Cells Trigger Personalized Anti-Tumor Cytotoxicity
Aug 26, 2026Thymus-Sparing Strategies Deserve Consideration in NSCLC Radiotherapy Planning
Aug 26, 2026Molecular Switch Driving Triple-Negative Breast Cancer Metastasis Identified
Aug 21, 2026Cancer Patients Could Access Broader Donor Pool for Stem Cell Transplantation
Aug 21, 2026Low-Carb Diets Dramatically Alter Gut Microbiome
Aug 26, 2026
Type 1 Diabetes Genetic Risk Score Improves MODY Diagnostic Pathway
Aug 26, 2026
Basking Biosciences Advances Reversible Clot-Busting Therapy for Acute Stroke
Aug 26, 2026
Replacing Lost Neurons Restores Memory in Mice with Alzheimer’s
Aug 26, 2026
Coronary Calcium Scans Sharpen Cardiovascular Risk Estimates
Aug 26, 2026
Smartphone App Provides Realtime Navigation for People with Vision Loss
Aug 24, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Cancer Diagnostics: Droplet Digital PCR Testing for HPV+ Cancer in the Clinic
In this IPM webinar, Chad Brenner, PhD, will describe the development, validation, and clinical implementation of MyHPVscore™, a droplet digital PCR-based circulating tumor HPV DNA assay performed on the Bio-Rad QX200 platform.
Chad Brenner, PhD
Associate Professor of Otolaryngology – Head & Neck Surgery
University of Michigan
Mouth-to-Gut Microbial Transmission Predicts Gastric and Colorectal Cancer
Aug 20, 2026A novel mouth-to-feces microbial index accurately differentiated patients with gastric and colorectal cancers from healthy controls and revealed disease-specific patterns of oral-to-gut bacterial transmission.
ctDNA From Blood Equals or Bests Tissue-Based Tests in Triple Negative Breast Cancer
Aug 19, 2026This blood-based ctDNA test helped predict recurrence as quickly or sooner than alternative, tumor biopsy-based tests. This could be a significant step forward in follow-up…
“Off-the-Shelf” CAR T-Cell Therapy Shows Mixed Early Results
Aug 19, 2026A Phase I study for a base edited 'off-the-shelf' CAR T-cell therapy for treatment of acute myeloid leukemia (AML) showed mixed safety and efficacy results.
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
FDA-Cleared Alzheimer’s Blood Test Marks a Shift Toward Earlier, Less Invasive Diagnosis
Universal Flu Vaccine Strategy Takes Aim at a Century-Old Viral Target
Beyond GLP-1s: Oral Small Molecule Targets Energy Expenditure to Fight Obesity
